They also had higher percentage of unfavorable outcomes (p < 0.0001), TACI type-strokes (p = 0.002), post-stroke medical complications (p < 0.0001), and higher CRP median levels (p < 0.0001) than those in the low NSE48h subgroup. This evidence concerns the gene CRP and stroke disorder.